← All stocks

Moderna, Inc.

MRNABiotechnologyLatest filing used: 2026-11-06Filings on SEC EDGAR ↗

Fast grower

Fair value per share

No filings-based value

Too few comparable years of filings.

Last close

$223.22

Nov 13, 2026

How we decide

Ten years of results

Revenue

$1.9B in FY2025, down 40% on the year before

FY2016: $108MFY2017: $206MFY2018: $135MFY2019: $60MFY2020: $803MFY2021: $18.5BFY2022: $19.3BFY2023: $6.8BFY2024: $3.2BFY2025: $1.9B$10B$20BFY16FY19FY22FY25$1.9B
Show as table
YearRevenue
FY2016$108M
FY2017$206M
FY2018$135M
FY2019$60M
FY2020$803M
FY2021$18.5B
FY2022$19.3B
FY2023$6.8B
FY2024$3.2B
FY2025$1.9B

Shares outstanding

Share count rose 18% over 9 years

FY2019: 331MFY2020: 381MFY2021: 431MFY2022: 416MFY2023: 382MFY2024: 384MFY2025: 389M0250M500MFY16FY19FY22FY25389M
Show as table
YearShares outstanding
FY2016–
FY2017–
FY2018–
FY2019331M
FY2020381M
FY2021431M
FY2022416M
FY2023382M
FY2024384M
FY2025389M

No cash earnings in the filings. No dividends paid in these years.

Delayed quote

Delayed price and chart from TradingView. This site does not receive or store these prices, and the fair value above does not use them. Showing the chart sends TradingView this page's address, the widget type, the ticker and your IP address, and TradingView may collect analytics; see Privacy.

Open on Yahoo Finance ↗

Sources. Company figures: SEC EDGAR (XBRL filings), latest filing used 2026-11-06. Interest rate: U.S. Treasury, 10-year par yield, 2026-11-13. Last close: IEX Historical Data, 2026-11-13.